Literature DB >> 19647617

Health-related quality of life and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Richard McQuellon1, Katie E Duckworth.   

Abstract

Mesh:

Year:  2009        PMID: 19647617     DOI: 10.1016/j.currproblcancer.2009.06.008

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  5 in total

1.  Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC).

Authors:  Katharine E Duckworth; Richard P McQuellon; Gregory B Russell; Craig S Cashwell; Perry Shen; John H Stewart; Edward A Levine
Journal:  J Surg Oncol       Date:  2012-03-22       Impact factor: 3.454

2.  Caregiver Quality of Life Before and After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Katharine E Duckworth; Richard P McQuellon; Gregory B Russell; Kathleen C Perry; Chandylen Nightingale; Perry Shen; Konstantinos I Votanopoulos; Bonny Morris; Edward A Levine
Journal:  J Am Coll Surg       Date:  2020-01-31       Impact factor: 6.113

3.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?

Authors:  V López-López; P A Cascales-Campos; E Gil; J Arevalo; A Gonzalez; J Gil; F C Muñoz-Casares; J T Melero; P Barrios; R Morales; I Ramos; G Ortega; B Camps; L González-Bayón; P Bretcha-Boix; J Farré-Alegre; S González-Moreno; P Parrilla
Journal:  Clin Transl Oncol       Date:  2017-08-10       Impact factor: 3.405

4.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease.

Authors:  Wenceslao Vásquez Jiménez; Luis González Bayón; José Luis García-Sabrido; Santiago González Moreno
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

5.  Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma.

Authors:  Yasmin M Ali; Joseph Sweeney; Perry Shen; Konstantinos I Votanopoulos; Richard McQuellon; Katie Duckworth; Kathleen C Perry; Greg Russell; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2019-05-08       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.